Successful management of immune thrombocytopenic purpura with thalidomide in a patient with multiple myeloma

Hematol J. 2004;5(5):456-7. doi: 10.1038/sj.thj.6200404.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Combined Modality Therapy
  • Drug Resistance
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Melphalan / therapeutic use
  • Middle Aged
  • Multiple Myeloma / complications
  • Multiple Myeloma / drug therapy*
  • Platelet Transfusion
  • Prednisone / therapeutic use
  • Purpura, Thrombocytopenic, Idiopathic / complications
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / therapy
  • Recurrence
  • Thalidomide / therapeutic use*

Substances

  • Antineoplastic Agents
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Thalidomide
  • Melphalan
  • Prednisone